Attenuation of postischemic microvascular disturbances in striated muscle by hyperosmolar saline dextran.
The underlying mechanisms of the beneficial therapeutic effects of small-volume resuscitation with hyperosmolar solutions for treatment of hypovolemic shock are still poorly understood. Using the dorsal skinfold chamber model and intravital fluorescence microscopy, we investigated the effects of hyperosmolar saline dextran on ischemia-reperfusion injury in striated skin muscle of awake normovolemic golden hamsters. Test solutions (4 ml/kg body wt i.v.) were administered 2 min before reperfusion after 4 h of pressure-induced ischemia. In animals receiving 0.9% saline (control), we observed a drastic enhancement of leukocyte rolling along and sticking to the endothelium of postcapillary venules 0.5 h after reperfusion. Postischemic leukocyte rolling and sticking were significantly reduced when animals were treated with 7.2% saline alone (HSS), 10% Dextran 60 in 0.9% saline (HDS), or 10% Dextran 60 in 7.2% saline (HHS). In control animals, capillary perfusion was reduced to approximately 60% of preischemic values 0.5 h after reperfusion. Concomitantly, leakage of the macromolecule fluorescein isothiocyanate-dextran (5 mg in 0.1 ml saline i.v., M(r) 150,000) into the perivascular space increased from 0% before ischemia to approximately 12% at 0.5 h reperfusion. In contrast, when animals were treated with HSS, HDS, or HHS before reperfusion, capillary perfusion decreased to a significantly minor extent of approximately 15%, and macromolecular leakage was slightly increased to approximately 5%. Our results suggest that hyperosmolar saline dextran effectively attenuates postischemic microvascular disturbances elicited by ischemia-reperfusion, presumably through reduction of postischemic leukocyte-endothelium interaction and capillary swelling.
D000818:Animals; D002196:Capillaries / Q000503:physiopathology; D002199:Capillary Permeability; D002448:Cell Adhesion / Q000187:drug effects; D006224:Cricetinae; D003911:Dextrans / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects; D007511:Ischemia / Q000503:physiopathology*; D007962:Leukocytes / Q000502:physiology; D046911:Macromolecular Substances; D008647:Mesocricetus; D008833:Microcirculation / Q000187:drug effects; D009132:Muscles / Q000098:blood supply*; D009994:Osmolar Concentration; D012039:Regional Blood Flow / Q000187:drug effects; D015424:Reperfusion; D012965:Sodium Chloride / Q000494:pharmacology*; D014661:Vasoconstriction
D003911:Dextrans; D046911:Macromolecular Substances; D012965:Sodium Chloride